Literature DB >> 19602971

No child left behind: Enrolling children and adults simultaneously in critical care randomized trials.

Scott D Halpern1, Adrienne G Randolph, Derek C Angus.   

Abstract

OBJECTIVE: : Randomized clinical trials of novel critical care interventions are currently tested in children only after documenting their safety in adults. Although this practice may protect children from research risks, it may paradoxically threaten children's well-being by depriving them of evidence to guide their care. We sought to evaluate the ethical, methodologic, and practical arguments for and against studying critical care interventions in adults and children simultaneously rather than sequentially. DATA SOURCE: : Empirical studies and conceptual arguments germane to the objective were reviewed. DATA EXTRACTION AND SYNTHESIS: : Children are traditionally viewed as "participants of last resort" due to their vulnerability and decisional incapacity. However, critically ill adults commonly share similar features. Thus, structured risk assessments used by Institutional Review Boards to determine the adequacy of research protections for critically ill adults can also help protect children. From a methodologic perspective, interventions may be tested simultaneously in children and adults by enrolling children as a prespecified subgroup within a larger adult randomized clinical trial or by enrolling children in a separate trial conducted in parallel. Both approaches raise practical and analytical challenges that can frequently be met. For example, investigators might choose outcome measures that are appropriate for both adults and children. Additionally, using Bayesian approaches to link the estimates of treatment effects in children to the values observed in adults may enhance the statistical power to detect pediatric-specific effects. Finally, centralized Institutional Review Boards and data monitoring centers may alleviate practical concerns with conducting trials among adults and children simultaneously.
CONCLUSIONS: : The current standard of testing critical care interventions in adults before children rests on tenuous ethical arguments and is entrenched by the methodologic and logistic barriers encountered with alternative approaches. However, these barriers will frequently be surmountable. We therefore propose that the default paradigm be changed such that interventions are examined routinely in critically ill children and adults simultaneously unless unique reasons exist to the contrary.

Entities:  

Mesh:

Year:  2009        PMID: 19602971      PMCID: PMC2903616          DOI: 10.1097/CCM.0b013e3181a59357

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  30 in total

Review 1.  The ethical analysis of risk.

Authors:  C Weijer
Journal:  J Law Med Ethics       Date:  2000       Impact factor: 1.718

2.  Research involving cognitively impaired adults.

Authors:  Jason H T Karlawish
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

3.  Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: a 2-year prospective cohort study.

Authors:  Alexis M Elward; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2006-05-31       Impact factor: 3.254

4.  The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations.

Authors:  John M Luce; Deborah J Cook; Thomas R Martin; Derek C Angus; Homer A Boushey; J Randall Curtis; John E Heffner; Paul N Lanken; Mitchell M Levy; Paula Y Polite; Graeme M Rocker; Robert D Truog
Journal:  Am J Respir Crit Care Med       Date:  2004-12-15       Impact factor: 21.405

5.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

6.  Eliciting and using expert opinions about influence of patient characteristics on treatment effects: a Bayesian analysis of the CHARM trials.

Authors:  Ian R White; Stuart J Pocock; Duolao Wang
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

7.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

8.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

Review 9.  Clinical trials in children.

Authors:  Patrina H Y Caldwell; Sharon B Murphy; Phyllis N Butow; Jonathan C Craig
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

10.  Transfusion strategies for patients in pediatric intensive care units.

Authors:  Jacques Lacroix; Paul C Hébert; James S Hutchison; Heather A Hume; Marisa Tucci; Thierry Ducruet; France Gauvin; Jean-Paul Collet; Baruch J Toledano; Pierre Robillard; Ari Joffe; Dominique Biarent; Kathleen Meert; Mark J Peters
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

View more
  4 in total

1.  Fluid balance in critically ill children with acute lung injury.

Authors:  Stacey L Valentine; Anil Sapru; Renee A Higgerson; Phillip C Spinella; Heidi R Flori; Dionne A Graham; Molly Brett; Maureen Convery; LeeAnn M Christie; Laurie Karamessinis; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2012-10       Impact factor: 7.598

Review 2.  Prone positioning in children with respiratory failure because of coronavirus disease 2019.

Authors:  Matthew K Leroue; Aline B Maddux; Peter M Mourani
Journal:  Curr Opin Pediatr       Date:  2021-06-01       Impact factor: 2.893

3.  Rigorous scoping review of randomized trials in pediatric critical care highlights need for a rigorous rethink.

Authors:  Adrienne G Randolph
Journal:  Crit Care       Date:  2013-12-20       Impact factor: 9.097

Review 4.  Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.

Authors:  Sharon Nachman; Amina Ahmed; Farhana Amanullah; Mercedes C Becerra; Radu Botgros; Grania Brigden; Renee Browning; Elizabeth Gardiner; Richard Hafner; Anneke Hesseling; Cleotilde How; Patrick Jean-Philippe; Erica Lessem; Mamodikoe Makhene; Nontombi Mbelle; Ben Marais; Helen McIlleron; David F McNeeley; Carl Mendel; Stephen Murray; Eileen Navarro; E Gloria Anyalechi; Ariel R Porcalla; Clydette Powell; Mair Powell; Mona Rigaud; Vanessa Rouzier; Pearl Samson; H Simon Schaaf; Seema Shah; Jeff Starke; Soumya Swaminathan; Eric Wobudeya; Carol Worrell
Journal:  Lancet Infect Dis       Date:  2015-05-06       Impact factor: 25.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.